Quantcast
Last updated on April 23, 2014 at 11:31 EDT

Latest Cystic fibrosis-related diabetes Stories

2012-10-25 11:23:36

First Drug to Treat the Cystic Fibrosis Defect was Developed in Collaboration With Cystic Fibrosis Foundation BETHESDA, Md., Oct. 25, 2012 /PRNewswire-USNewswire/ -- Kalydeco(TM), the first drug to treat the underlying cause of cystic fibrosis, has won The Wall Street Journal's 2012 Technology Innovation Award in the Medicine and Biotech category. The awards recognize technological breakthroughs that are game-changers or have a wide impact in their field and beyond. Kalydeco was...